ENDRA Life Sciences Inc.

NasdaqCM:NDRA Stock Report

Market Cap: US$2.7m

ENDRA Life Sciences Dividends and Buybacks

Dividend criteria checks 0/6

ENDRA Life Sciences does not have a record of paying a dividend.

Key information

n/a

Dividend yield

-392.8%

Buyback Yield

Total Shareholder Yield-392.8%
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

No updates

Recent updates

ENDRA to submit FDA De Novo request for liver disease monitoring system in coming weeks

Sep 29

ENDRA Life Sciences receives European patent for TAEUS system

Aug 24

Endra Life Sciences Q2 2022 Earnings Preview

Aug 12

We're A Little Worried About ENDRA Life Sciences' (NASDAQ:NDRA) Cash Burn Rate

Aug 08
We're A Little Worried About ENDRA Life Sciences' (NASDAQ:NDRA) Cash Burn Rate

We're Keeping An Eye On ENDRA Life Sciences' (NASDAQ:NDRA) Cash Burn Rate

Nov 18
We're Keeping An Eye On ENDRA Life Sciences' (NASDAQ:NDRA) Cash Burn Rate

We Think ENDRA Life Sciences (NASDAQ:NDRA) Needs To Drive Business Growth Carefully

Jul 19
We Think ENDRA Life Sciences (NASDAQ:NDRA) Needs To Drive Business Growth Carefully

ENDRA Life Sciences names Irina Pestrikova Principal Financial Officer

Jun 15

ENDRA Life Sciences granted 13th U.S. Patent for its TAEUS platform technology

Jan 13

ENDRA Life Sciences renews GE Healthcare collaboration agreement

Dec 21

Endra Life prices $5M-share offering

Dec 16

Endra Life Sciences EPS beats by $0.02

Nov 16

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if NDRA's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if NDRA's dividend payments have been increasing.


Dividend Yield vs Market

ENDRA Life Sciences Dividend Yield vs Market
How does NDRA dividend yield compare to the market?
SegmentDividend Yield
Company (NDRA)n/a
Market Bottom 25% (US)1.4%
Market Top 25% (US)4.2%
Industry Average (Medical Equipment)1.6%
Analyst forecast (NDRA) (up to 3 years)n/a

Notable Dividend: Unable to evaluate NDRA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate NDRA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate NDRA's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as NDRA has not reported any payouts.


Discover strong dividend paying companies